BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33780367)

  • 1. Screening for Early-Stage Alzheimer's Disease Using Optimized Feature Sets and Machine Learning.
    Kleiman MJ; Barenholtz E; Galvin JE;
    J Alzheimers Dis; 2021; 81(1):355-366. PubMed ID: 33780367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Episodic-Memory Performance in Machine Learning Modeling for Predicting Cognitive Health Status Classification.
    Bergeron MF; Landset S; Tarpin-Bernard F; Ashford CB; Khoshgoftaar TM; Ashford JW
    J Alzheimers Dis; 2019; 70(1):277-286. PubMed ID: 31177223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities Questionnaire.
    Sato K; Niimi Y; Ihara R; Suzuki K; Iwata A; Iwatsubo T; ;
    J Alzheimers Dis; 2024; 99(3):953-963. PubMed ID: 38759009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease: a feature selection ensemble combining stability and predictability.
    Pereira T; Ferreira FL; Cardoso S; Silva D; de Mendonça A; Guerreiro M; Madeira SC;
    BMC Med Inform Decis Mak; 2018 Dec; 18(1):137. PubMed ID: 30567554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning Analysis of Digital Clock Drawing Test Performance for Differential Classification of Mild Cognitive Impairment Subtypes Versus Alzheimer's Disease.
    Binaco R; Calzaretto N; Epifano J; McGuire S; Umer M; Emrani S; Wasserman V; Libon DJ; Polikar R
    J Int Neuropsychol Soc; 2020 Aug; 26(7):690-700. PubMed ID: 32200771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
    Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Clinical Dementia Rating Using Blood RNA Levels.
    Miller JB; Kauwe JSK
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32604772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep Learning and Risk Score Classification of Mild Cognitive Impairment and Alzheimer's Disease.
    Nagaraj S; Duong TQ
    J Alzheimers Dis; 2021; 80(3):1079-1090. PubMed ID: 33646166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of MemTrax and Machine Learning Modeling in Classification of Mild Cognitive Impairment.
    Bergeron MF; Landset S; Zhou X; Ding T; Khoshgoftaar TM; Zhao F; Du B; Chen X; Wang X; Zhong L; Liu X; Ashford JW
    J Alzheimers Dis; 2020; 77(4):1545-1558. PubMed ID: 32894241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting Treatment Group Differences in Alzheimer's Disease Clinical Trials: A Comparison of Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) and the Clinical Dementia Rating - Sum of Boxes (CDR-SB).
    Wessels AM; Dowsett SA; Sims JR
    J Prev Alzheimers Dis; 2018; 5(1):15-20. PubMed ID: 29405227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-Term Memory Binding Distinguishing Amnestic Mild Cognitive Impairment from Healthy Aging: A Machine Learning Study.
    Martínez-Florez JF; Osorio JD; Cediel JC; Rivas JC; Granados-Sánchez AM; López-Peláez J; Jaramillo T; Cardona JF
    J Alzheimers Dis; 2021; 81(2):729-742. PubMed ID: 33814438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.
    Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY
    J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Profiles of Arteriolosclerosis and Alzheimer Disease at Mild Cognitive Impairment and Mild Dementia in a National Neuropathology Cohort.
    Yang D; Masurkar AV
    Alzheimer Dis Assoc Disord; 2021 Jan-Mar 01; 35(1):14-22. PubMed ID: 32925200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the Clinical Dementia Rating Scale Sum of Boxes in Staging and Detection of Cognitive Impairment in Mexican Americans.
    Julayanont P; DeToledo JC
    J Geriatr Psychiatry Neurol; 2022 Jan; 35(1):128-134. PubMed ID: 33261535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories.
    Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H
    Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability and validity of A Quick Test of Cognitive Speed for detecting early-stage dementia in elderly Japanese.
    Takahashi F; Awata S; Sakuma N; Inagaki H; Ijuin M
    Psychogeriatrics; 2012 Jun; 12(2):75-82. PubMed ID: 22712639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.